🧠AI AnalysisStudy Highlights Significant Insurance Delays and Denials for Pediatric Biologic Prescriptions
New research presented at the American College of Allergy, Asthma and Immunology annual meeting reveals that nearly 40% of pediatric biologic prescriptions needing prior …